Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

Q&A med Zealand Pharma, 23 August kl 15.00 Læs mere her
      
side 1 / 243
Opret nyt indlæg

H+H
16/8 09:40 TeamGarlic Svar: 0

Screener
12/8 17:19 donprebsi Svar: 1

GENMAB - Transcript fra Q&A 9.aug. 2018
10/8 22:28 Helge Larsen/PI-redaktør Svar: 0

Pandora
10/8 09:47 goldencross Svar: 0

Maha Energy
9/8 17:34 MikThi Svar: 1

Shortpositioner DK ultimo juli 2018
8/8 07:27 Helge Larsen/PI-redaktør Svar: 0

Questerre
5/8 22:26 benjaminboe Svar: 1

Laksektoren - Oversigt på aktieudbytter
5/8 09:54 Helge Larsen/PI-redaktør Svar: 0

Daratumumab is one of the most promising ne..
27/7 06:02 Helge Larsen/PI-redaktør Svar: 0

Uran som investeringcase
26/7 12:07 Helge Larsen/PI-redaktør Svar: 2

Risk Intelligence
20/7 12:24 jeppe13 Svar: 1

Træ og skov
17/7 17:30 LeonHobro Svar: 0

Norske pengemaskiner
9/7 17:36 Helge Larsen/PI-redaktør Svar: 4

Ørsted
9/7 11:55 MikThi Svar: 1

Grøn handler - hvordan får jeg foden indenf..
19/6 20:52 rayman61 Svar: 6

Hvor bredt skal jeg gå?
17/6 21:28 MikThi Svar: 2

Mærsk analyse
8/6 23:20 MikThi Svar: 2

Aflæsning af Nøgletal, en hurtig introdukti..
27/5 21:02 thealtchemist Svar: 2

Darzalex salgstal estimeret 2018 ?
26/5 18:28 peter12 Svar: 3

New Wave Group
17/5 14:18 omardjurhuus Svar: 2

Beregne kurs ud fra nøgletal (
17/5 11:47 PeterS88 Svar: 2

Teva
15/5 16:19 omardjurhuus Svar: 0

TA af Tesla
12/5 13:17 MKHO0001 Svar: 1

Kloge råd til ny invester søges
10/5 17:03 AAndersS Svar: 3

Flot kvartal for Intel
26/4 22:53 Occam Svar: 0

Dara salgstal 2018
15/4 15:41 Vester Svar: 0

Afgivelse af stop-limit ordre med uheldig u..
8/4 10:50 aktiegeek Svar: 3

nøgletal
25/3 11:48 ah1980 Svar: 1

AQR shorts i Genmab
11/3 14:29 peter12 Svar: 3

Tørlast og Allergivacciner i fokus
9/3 11:32 collersteen Svar: 0

Bull markedets fjender.
3/3 12:07 HeyimnotCram Svar: 0

GENMAB - RESUMÈ
22/2 08:12 Helge Larsen/PI-redaktør Svar: 6

Riget fattes penge, Helge sender hatten run..
21/2 13:08 Tyndeejner Svar: 2

GEN - Spørgsmål fra Hollandsk investor
4/2 23:33 Helge Larsen/PI-redaktør Svar: 2

US tax reform udfordrer regnskabsanalyserne.
26/1 01:02 Occam Svar: 2

Zealand Pharma - Kapitalmarkedsdag Københav..
24/1 12:39 Helge Larsen/PI-redaktør Svar: 1

Zealand Pharma announces progress to Phase..
20/1 10:07 Helge Larsen/PI-redaktør Svar: 0

Shalegas og QEC
13/1 13:48 Mcjean Svar: 3

GENMAB Indlæg af ROI (David Mygind)
8/1 13:06 Darvin Svar: 2

Johnson og Johnson
6/1 12:52 MoneyMasterdk Svar: 0

Godt nytår
31/12 17:15 Helge Larsen/PI-redaktør Svar: 5

MYTER OM BITCOIN
29/12 19:48 LetThereBeFire Svar: 2

NUEVOLUTION ANALYSE
22/12 07:53 Helge Larsen/PI-redaktør Svar: 2

ZEALAND PHARMA: Q&A d. 12. december 2017
12/12 19:41 Helge Larsen/PI-redaktør Svar: 0

Torm
8/12 18:58 log Svar: 0

sikker havn
23/11 10:13 Boblefisken Svar: 2

PI aktiekurser
15/11 12:42 CLM 46 Svar: 1

Næst-længste aktie-rally siden 2. verdenskr..
15/11 12:07 TeamGarlic Svar: 0

US Recepttal. Realiseret og Estimeret
15/11 11:56 JørgenVarnæs Svar: 8


GEN - Spørgsmål fra Hollandsk investor

  


"Dear Helge Larsen,


I am a fellow investor in Genmab for more than 10 years and therefore an avid reader of any information concerning the stock. I subscribe to Blogbuster and read, via Google translate, the ProInvestor forum. Although I am not interested in becoming an active member, lacking detailed knowledge, I do have a question which could be of interest to the forum. Perhaps you could answer or post this view on the forum.


My question concerns the short-selling and possible strategy:


There is possibly a huge disconnect between the market-value and the intrinsic-value: some suggest a takeout-value 4-times as high,
ownership is concentrated with large parties: > 60% in firm hands, not willing to sell for anything less than the intrinsic-value,
Big Farma is in need to replenish their pipeline, paying top-dollar for takeovers,
Genmab could be next/ will be next....


Now suppose I am a big player and I sell short. I use the proceeds to buy a bull product: turbo, cfd, and what not:

The short-selling keeps the share-price under pressure: I can buy my turbo, bull certificates even lower...(or even regular shares if I want to build a position)
If the share drops even more, I lose on the turbo, but I can close my short position,
If the share rises, the gains on the turbo are much higher than the loss on the short position,
If there is a takeover, I can gain even more by creating/contributing to a short-squeeze and then selling my turbo at the self created peak and closing the short position.


I hope I did not make a total fool of myself by asking this question.


Wishing you, your forum, an Genmab all the best from the Netherlands",

XXXXXXXX



Very good question.
The trick is the first scenario: if share price drops you lose on the turbo. It could actually be worthless. Where is the equilibrium in this trade ?
For scenario 2 you will have to find the equilibrium for the gains on the turbo compared to the loss on the short position.

Now this includes math to a high degree, but also your expectations for the share price. I'd say this is not easy to calculate. You will have to pay for a premium for the short position and pay recurring fees for the turbo.

For me this would be a no-go. I'd rather watch the TA and trade the stock.



I suppose this is similar to betting on two opposite outcomes using different odds at different brokers. It may be possible to create a sure-win situation for yourself.

I see three problems in your case:

1. You may be accused of illegal stock market manipulation.

2. Since your counterparts are professionals your marginal gain could be quite small. So to make the operation worthwhile you must do the operation on a grand scale. This could affect the market prices so your advantage disappears.

3. If you succeed on a grand scale somebody else may go broke so you will not able to collect your gain. After all shorts and bulls are not guaranteed by the taxpayers.

Occam 2 76052 8/2 2018 10:34 STEM OP SVAR



side 1 / 243
Opret nyt indlæg